Effective July 31, 2026.
Limited safety information
The FDA has identified limited or inadequate safety information and potential risks associated with several peptide ingredients listed on this storefront, including BPC-157, CJC-1295, Ipamorelin, and Thymosin Alpha-1. Ingredient-specific risks can vary by route, formulation, and individual circumstances.
Not a substitute for medical care
Do not use this website to diagnose a condition, select treatment, replace prescribed care, or evaluate interactions. A qualified healthcare professional should review the complete final label, your medications, health history, and individual risk factors before you consider use.
Who should not rely on this website
Products are intended only for adults. Do not consider use while pregnant or nursing, for a minor, or when managing a medical condition or taking medication without individualized professional guidance. Stop and seek medical attention for a suspected adverse reaction.
Manufacturing claims are not approval
cGMP production, raw-material verification, batch testing, and stability testing are manufacturing quality controls reported by our manufacturing partner. They do not establish FDA approval or prove that a product is safe or effective for a particular use.
Official information
Review the FDA’s information on bulk drug substances that may present significant safety risks. Regulatory status can change; obtain current professional advice before ordering.